Slide 1A MEDICINE PRICES SURVEY IN CHINA Presentation by Dr Xiaoxia Hu Research by Dr Sun Qiang and Dr Xiaoxia Hu June, 2006 Slide 2 Sectors and facilities surveyed 5 private…

Slide 1Pharmaceutical Policy Reform in Korea Tae-Jin Lee, PhD. Seoul National University, Korea Slide 2 Outline Korean Health Care System Policy background New pharmaceutical…

1. when more is not enough The birth story of the world’s only treatment for Dysphoric Social Attention Consumption Deficit Anxiety Disorder 2. Why make another pharmaceutical?…

Financial Crime Compliance 1 Financial Crime Compliance Standard Chartered Bank Leading the way in combating financial crime. Financial Crime Compliance 2 #2 = Health $21.8…

1. ASMI Conference Australia November 2014 v14 290914 2. Steve Sowerby CEO and Founder XPotential Postcards From Around The World Global Healthcare Trends in Self-Medication…

1. r e l e a s e d: m a r c h 3 1, 2 0 1 5 Cost-drivers of public drug plans in canada E l e n a l u n g u Manager, NPDUIS, PMPRB 2015 CADTH Symposium 2. About NPDUIS …

Practice Questions to accompany Mankiw & Taylor: Economics 1 Practice Questions Chapter 1 1. People respond to incentives. Governments can alter incentives and, hence,…

Slide 1 Cost-effective Prescribing Dr. Máirín Ryan Slide 2 Pharmacoeconomics Pharmacoeconomics: that branch of health economics that focuses upon the costs and benefits…

Slide 1 Direct-to-Consumer Advertising of Prescription Drugs: Looking Back, Looking Forward Kathryn J. Aikin, Ph.D. Division of Drug Marketing, Advertising and Communications,…

Slide 1 D RUG P ATENTING AND ITS E FFECTS ON P HARMACEUTICAL F IRMS With an Emphasis on the Gleevec Patent Case Slide 2 C ONTENTS Patent Laws in: India U.S.A. China Russia…